Comment on India Cancer Ruling Opens Door For Cheaper Drugs

India Cancer Ruling Opens Door For Cheaper Drugs

* Indian authorities issue first compulsory license * Drugmakers target India growth, but wary of patent regulations * HIV/AIDS, heart disease treatments targeted by campaigners (Adds link, smends headline) By Kaustubh Kulkarni and Henry Foy MUMBAI, March 13 (Reuters) - India's move to strip German drugmaker Bayer of its exclusive rights to a cancer drug has set a precedent that could extend to other treatments, including modern HIV/AIDS drugs, in a major blow to global pharmaceutical firms, experts say.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News